Air Products & Chemicals (APD) Earnings Analysis

Air Products & Chemicals (APD) delivered mixed results in FY2026 on revenue of $130.2B versus the $132.7B estimate (+18.3% YoY) and EPS of $3.93. Below is the full Air Products & Chemicals earnings breakdown — the risk-adjusted verdict, price forecast, technicals, options and hedge-fund 13F holdings, decoded in plain English.

Air Products & Chemicals (APD) Earnings Analysis — key stats

Next earnings dateFeb 4, 2025
Latest reported quarterFY2026
Earnings verdictMixed
Revenue$130.2B (vs $132.7B est · -1.9% surprise · +18.3% YoY)
EPS$3.93 (vs $3.69 est · +6.5% surprise · +0.3% YoY)
Share price$308.04 (-2.4%)
Market cap$1.92T

What you'll find

Frequently asked questions

When is Air Products & Chemicals's next earnings date?
Air Products & Chemicals's (APD) next scheduled earnings date is Feb 4, 2025. Magnisto shows the confirmed date, the options-implied expected move and the revenue and EPS estimates Wall Street is modeling into the report.
Did Air Products & Chemicals (APD) beat or miss earnings?
In FY2026, Air Products & Chemicals (APD) posted mixed results — revenue of $130.2B versus the $132.7B estimate (-1.9% surprise) and EPS of $3.93 versus $3.69 expected (+6.5% surprise). Magnisto decodes every Air Products & Chemicals (APD) report into a clear Beat, Miss, In-line or Mixed verdict and checks whether guidance was raised, held or cut.
What is the forecast for Air Products & Chemicals (APD) stock?
Magnisto blends analyst price targets, quantitative research, technical trend and options-implied moves into a scenario range for Air Products & Chemicals (APD), anchored to the current $308.04 share price, so you can weigh the bull, base and bear cases for Air Products & Chemicals side by side.
Is Air Products & Chemicals (APD) a buy right now?
Magnisto does not give buy or sell tips. It gives you the institutional-grade evidence — the verdict, valuation, risks, technicals and hedge-fund 13F flows — so you can decide whether Air Products & Chemicals fits your own thesis and risk profile. This is research, not investment advice.

Related stocks

Educational research, not investment advice. Figures are illustrative and may be delayed.